BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 10053111)

  • 1. Predicting pelvic lymph node metastasis in endometrial carcinoma.
    Kamura T; Yahata H; Shigematsu T; Ogawa S; Amada S; Kaku T; Nakano H
    Gynecol Oncol; 1999 Mar; 72(3):387-91. PubMed ID: 10053111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Para-aortic lymphadenectomy may improve disease-related survival in patients with multipositive pelvic lymph node stage IIIc endometrial cancer.
    Fujimoto T; Nanjyo H; Nakamura A; Yokoyama Y; Takano T; Shoji T; Nakahara K; Yamada H; Mizunuma H; Yaegashi N; Sugiyama T; Kurachi H; Sato A; Tanaka T
    Gynecol Oncol; 2007 Nov; 107(2):253-9. PubMed ID: 17640720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indispensability of pelvic and paraaortic lymphadenectomy in endometrial cancers.
    Yokoyama Y; Maruyama H; Sato S; Saito Y
    Gynecol Oncol; 1997 Mar; 64(3):411-7. PubMed ID: 9062142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Multivariate analysis of prognostic factors in endometrial carcinoma].
    Li B; Wu LY; Li SM; Zhang WH; Zhang R; Ma SK
    Ai Zheng; 2004 Sep; 23(9):1085-8. PubMed ID: 15363208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is it possible to predict para-aortic lymph node metastasis in endometrial cancer?
    Turan T; Hizli D; Sarici S; Boran N; Gundogdu B; Karadag B; Tulunay G; Kose MF
    Eur J Obstet Gynecol Reprod Biol; 2011 Oct; 158(2):274-9. PubMed ID: 21664758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of preoperative criteria used to predict lymph node metastasis in endometrial cancer.
    Han SS; Lee SH; Kim DH; Kim JW; Park NH; Kang SB; Song YS
    Acta Obstet Gynecol Scand; 2010; 89(2):168-74. PubMed ID: 19916890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of pelvic lymphadenectomy on prognosis of endometrial carcinoma].
    Wen HW; Zhang LD
    Zhonghua Fu Chan Ke Za Zhi; 2004 Mar; 39(3):152-5. PubMed ID: 15130370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of preoperative serum CA-125 levels for prediction of lymph node metastasis and prognosis in endometrial cancer.
    Chung HH; Kim JW; Park NH; Song YS; Kang SB; Lee HP
    Acta Obstet Gynecol Scand; 2006; 85(12):1501-5. PubMed ID: 17260229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological risk factors for pelvic lymph node metastasis in clinical early-stage endometrioid endometrial adenocarcinoma.
    Zhang C; Wang C; Feng W
    Int J Gynecol Cancer; 2012 Oct; 22(8):1373-7. PubMed ID: 22932266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
    Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
    Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percent surface area involvement is a predictor of lymph node metastasis in endometrial cancer.
    Axtell AE; Kelley JL; Fader AN; Gupta D; Schwartz B; Comerci JT; Lin Y; Weiand S; Gallion HH; Kanbour-Shakir A
    Gynecol Oncol; 2007 Dec; 107(3):482-6. PubMed ID: 17850853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histopathological prognostic factors predicting para-aortic lymph node metastasis in patients with endometrioid uterine cancer.
    Karube Y; Fujimoto T; Takahashi O; Nanjyo H; Mizunuma H; Yaegashi N; Sugiyama T; Kurachi H; Sato A; Tanaka T
    Gynecol Oncol; 2010 Aug; 118(2):151-4. PubMed ID: 20621776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pelvic lymph node metastasis in endometrial cancer with no myometrial invasion.
    Takeshima N; Hirai Y; Tanaka N; Yamawaki T; Yamauchi K; Hasumi K
    Obstet Gynecol; 1996 Aug; 88(2):280-2. PubMed ID: 8692516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of serous and clear cell adenocarcinoma in surgically staged endometrial carcinoma.
    Sakuragi N; Hareyama H; Todo Y; Yamada H; Yamamoto R; Fujino T; Sagawa T; Fujimoto S
    Acta Obstet Gynecol Scand; 2000 Apr; 79(4):311-6. PubMed ID: 10746848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology.
    Lutman CV; Havrilesky LJ; Cragun JM; Secord AA; Calingaert B; Berchuck A; Clarke-Pearson DL; Soper JT
    Gynecol Oncol; 2006 Jul; 102(1):92-7. PubMed ID: 16406063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The novel criteria for predicting pelvic lymph node metastasis in endometrioid adenocarcinoma of endometrium.
    Akbayir O; Corbacioglu A; Goksedef BP; Numanoglu C; Akca A; Guraslan H; Bakir LV; Cetin A
    Gynecol Oncol; 2012 May; 125(2):400-3. PubMed ID: 22310644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of progesterone receptor immunohistochemistry for lymph node metastases in endometrial carcinoma.
    Iwai K; Fukuda K; Hachisuga T; Mori M; Uchiyama M; Iwasaka T; Sugimori H
    Gynecol Oncol; 1999 Mar; 72(3):351-9. PubMed ID: 10053107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of gross myometrial invasion with endometrial cancer.
    Larson DM; Connor GP; Broste SK; Krawisz BR; Johnson KK
    Obstet Gynecol; 1996 Sep; 88(3):394-8. PubMed ID: 8752246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prognostic factors in diagnosed endometrial cancers determining the type of radical surgery].
    Ivanov S; Tomov S
    Akush Ginekol (Sofiia); 2009; 48(3):14-9. PubMed ID: 20198758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.
    Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR
    Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.